Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition

References

• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48
   PubMed Web of Science ®Google Scholar
• Anderson M, Omri A. (2004). The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Deliv 11:33–9
   PubMed Web of Science ®Google Scholar
• Beseničar MP, Bavdek A, Kladnik A, et al. (2008). Kinetics of cholesterol extraction from lipid membranes by methyl-beta-cyclodextrin-a surface plasmon resonance approach. Biochim Biophys Acta 1778:175–84
   PubMed Web of Science ®Google Scholar
• Chang HI, Yeh MK. (2012). Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine 7:49–60
   PubMed Web of Science ®Google Scholar
• Chen J, Cai BC, Ping QN, et al. (2008). Lactone stability and tissue distribution of free and liposomal encapsulated 9-nitrocamptothecin in rats following intravenous injection. Drug Dev Ind Pharm 34:853–9
   PubMed Web of Science ®Google Scholar
• Chen J, Cheng D, Li J, et al. (2013). Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC. Drug Dev Ind Pharm 39:197–204
   PubMed Web of Science ®Google Scholar
• Chen J, Lin AH, Chen ZP, et al. (2010). Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro. Drug Dev Ind Pharm 36:245–53
   PubMed Web of Science ®Google Scholar
• Chen J, Lu SS, Gu W, et al. (2015). Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor. Int J Pharm 490:219–28
   PubMed Web of Science ®Google Scholar
• Chen J, Lu WL, Gu W, et al. (2014). Drug-in-cyclodextrin-in liposomes: a promising delivery system for hydrophobic drugs. Expert Opin Drug Deliv 11:565–77
   PubMed Web of Science ®Google Scholar
• Cheng Y, Yu SL, Wang JJ, et al. (2012). In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles. Macromol Biosci 12:1326–35
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Mirahmadi N, Babaei MH, et al. (2010). Peritoneal retention of liposomes: effects of lipid composition, PEG coating and liposome charge. J Control Release 148:177–86
   PubMed Web of Science ®Google Scholar
• Deilarduya CT, Düzgünes N. (2013). Delivery of therapeutic nucleic acids via transferring and transferring receptors: lipoplexes and other carriers. Expert Opin Drug Deliv 10:1583–91
   PubMed Web of Science ®Google Scholar
• Dietrich MA, Zmijewski D, Karol H, et al. (2010). Isolation and characterization of transferrin from common carp (Cyprinus carpio L) seminal plasma. Fish Shellfish Immunol 29:66–74
   PubMed Web of Science ®Google Scholar
• Dini L, Falasca L, Ruzzittu MT, et al. (1998). Interaction between isolated and purified liver cells and small unilamellar liposomes. Liver 18:229–38
   PubMedGoogle Scholar
• Doi A, Kawabata S, Iida K, et al. (2008). Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. J Neurooncol 87:287–94
   PubMed Web of Science ®Google Scholar
• Gandhi R, Khatri N, Baradia D, et al. (2015). Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7. Drug Deliv 25. [Epub ahead of print]. doi: 10.3109/10717544.2014.999960
   Web of Science ®Google Scholar
• Gharib R, Greige-Gerges H, Fourmentin S, et al. (2015). Liposomes incorporating cyclodextrin-drug inclusion complexes: current state of knowledge. Carbohydr Polym 129:175–86
   PubMed Web of Science ®Google Scholar
• Hatzi P, Mourtas S, Klepetsanis PG, et al. (2007). Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition. Int J Pharm 333:167–76
   PubMed Web of Science ®Google Scholar
• Hong M, Zhu S, Jiang Y, et al. (2009). Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release 133:96–102
   PubMed Web of Science ®Google Scholar
• Lehrer S. (1971). Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 10:3254–63
   PubMed Web of Science ®Google Scholar
• Li X, Ding L, Xu Y, et al. (2009). Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 373:116–23
   PubMed Web of Science ®Google Scholar
• Matloob AH, Mourtas S, Klepetsanis P, et al. (2014). Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study. Int J Pharm 476:108–15
   PubMed Web of Science ®Google Scholar
• McCormack B, Gregoriadis G. (1994). Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target 2:449–54
   PubMed Web of Science ®Google Scholar
• McCormack B, Gregoriadis G. (1996). Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-b-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta 1291:237–44
   PubMed Web of Science ®Google Scholar
• McKeage MJ, Berners-Price SJ, Galettis P, et al. (2000). Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes. Cancer Chemother Pharmacol 46:343–50
   PubMed Web of Science ®Google Scholar
• Mendonça EA, Lira MC, Rabello MM, et al. (2012). Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes. AAPS PharmSciTech 1:1355–66
   Google Scholar
• Nii T, Ishii F. (2005). Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198–205
   PubMed Web of Science ®Google Scholar
• Peng Q, Wei X, Yang Q, et al. (2015). Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona. Nanomedicine (Lond) 10:205–14
   PubMed Web of Science ®Google Scholar
• Qian S, Li C, Zuo Z. (2012). Pharmacokinetics and disposition of various drug loaded liposomes. Curr Drug Metab 13:372–95
   PubMed Web of Science ®Google Scholar
• Rahman S, Cao S, Steadman KJ, et al. (2012). Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer. Drug Deliv 19:346–53
   PubMed Web of Science ®Google Scholar
• Stewart JC. (1980). Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10–14
   PubMed Web of Science ®Google Scholar
• van den Hoven JM, Metselarr JM, Storm G, et al. (2012). Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes. Int J Pharm 438:209–16
   PubMed Web of Science ®Google Scholar
• Wang X, Deng L, Cai L, et al. (2011). Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome. J Pharm Sci 100:3357–64
   PubMed Web of Science ®Google Scholar
• Wei M, Xu Y, Zou Q, et al. (2012). Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. Eur J Pharm Sci 46:131–41
   PubMed Web of Science ®Google Scholar
• Yan Z, Zhu ZL, Qian ZZ, et al. (2012). Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors. Acta Pharmacol Sin 33:852–8
   PubMed Web of Science ®Google Scholar
• Yuan MQ, Zhu F, Lou JY, et al. (2014). The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer. Drug Res 64:195–202
   PubMedGoogle Scholar
• Zhang J, Ma PX. (2013). Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 65:1215–33
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiang J, Liu Y, et al. (2011). Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride. Bioorg Med Chem Lett 21:5982–6
   PubMed Web of Science ®Google Scholar
• Zhang XF, Yang G, Dong Y, et al. (2015). Studies on the binding of fulvic acid with transferrin by spectroscopic analysis. Spectrochim Acta Mol Biomol Spectrosc 137:1280–5
   PubMed Web of Science ®Google Scholar
• Zhou X, Yung B, Huang Y, et al. (2012). Novel liposomal gefitinib (L-GEF) formulations. Anticancer Res 32:2919–24
   PubMed Web of Science ®Google Scholar